PAK4 Signaling in Health and Disease: Defining the PAK4-CREB Axis

Overview

Journal Exp Mol Med

Specialties Biochemistry
Molecular Biology

Date 2019 Feb 14

PMID 30755582

Citations 33

Authors

So-Yoon Won

Jung-Jin Park

Eun-Young Shin

Eung-Gook Kim

Affiliations

Soon will be listed here.

Abstract

p21-Activated kinase 4 (PAK4), a member of the PAK family, regulates a wide range of cellular functions, including cell adhesion, migration, proliferation, and survival. Dysregulation of its expression and activity thus contributes to the development of diverse pathological conditions. PAK4 plays a pivotal role in cancer progression by accelerating the epithelial-mesenchymal transition, invasion, and metastasis. Therefore, PAK4 is regarded as an attractive therapeutic target in diverse types of cancers, prompting the development of PAK4-specific inhibitors as anticancer drugs; however, these drugs have not yet been successful. PAK4 is essential for embryonic brain development and has a neuroprotective function. A long list of PAK4 effectors has been reported. Recently, the transcription factor CREB has emerged as a novel effector of PAK4. This finding has broad implications for the role of PAK4 in health and disease because CREB-mediated transcriptional reprogramming involves a wide range of genes. In this article, we review the PAK4 signaling pathways involved in prostate cancer, Parkinson's disease, and melanogenesis, focusing in particular on the PAK4-CREB axis.

Citing Articles

The Important Role of p21-Activated Kinases in Pancreatic Exocrine Function.

Ramos-Alvarez I, Jensen R Biology (Basel). 2025; 14(2).

PMID: 40001881 PMC: 11851965. DOI: 10.3390/biology14020113.

PAK4 promotes the cytoskeletal organization and meiotic maturation via phosphorylating DDX17 in oocyte.

Wang H, Gao M, Cheng Q, Zhu S, Chen Y, Gu L Cell Commun Signal. 2025; 23(1):85.

PMID: 39948582 PMC: 11827469. DOI: 10.1186/s12964-025-02085-3.

Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer.

Wahi K, Freidman N, Wang Q, Devadason M, Quek L, Pang A EMBO J. 2024; 43(23):5857-5882.

PMID: 39420093 PMC: 11611898. DOI: 10.1038/s44318-024-00271-6.

Inhibition of NAMPT by PAK4 Inhibitors.

Wang Y, Minden A Int J Mol Sci. 2024; 25(18).

PMID: 39337621 PMC: 11431865. DOI: 10.3390/ijms251810138.

Biological Functions and Therapeutic Potential of NAD Metabolism in Gynecological Cancers.

Myong S, Nguyen A, Challa S Cancers (Basel). 2024; 16(17).

PMID: 39272943 PMC: 11394644. DOI: 10.3390/cancers16173085.

References

Manser E, Leung T, Salihuddin H, Zhao Z, Lim L . A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature. 1994; 367(6458):40-6. DOI: 10.1038/367040a0. View

Nobes C, Hall A . Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol. 1999; 144(6):1235-44. PMC: 2150589. DOI: 10.1083/jcb.144.6.1235. View

Manser E, Lim L . Roles of PAK family kinases. Prog Mol Subcell Biol. 1999; 22:115-33. DOI: 10.1007/978-3-642-58591-3_6. View

Arias-Romero L, Chernoff J . A tale of two Paks. Biol Cell. 2008; 100(2):97-108. DOI: 10.1042/BC20070109. View

Chenette E, Mitin N, Der C . Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity. Mol Biol Cell. 2006; 17(7):3108-21. PMC: 1483044. DOI: 10.1091/mbc.e05-09-0896. View

Ha B, Boggon T . CDC42 binds PAK4 via an extended GTPase-effector interface. Proc Natl Acad Sci U S A. 2018; 115(3):531-536. PMC: 5776996. DOI: 10.1073/pnas.1717437115. View

Du K, Montminy M . CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem. 1998; 273(49):32377-9. DOI: 10.1074/jbc.273.49.32377. View

Finkbeiner S . New roles for introns: sites of combinatorial regulation of Ca2+- and cyclic AMP-dependent gene transcription. Sci STKE. 2001; 2001(94):pe1. DOI: 10.1126/stke.2001.94.pe1. View

Mayr B, Montminy M . Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001; 2(8):599-609. DOI: 10.1038/35085068. View

10.

Wen A, Sakamoto K, Miller L . The role of the transcription factor CREB in immune function. J Immunol. 2010; 185(11):6413-9. PMC: 5519339. DOI: 10.4049/jimmunol.1001829. View

11.

Shaywitz A, Greenberg M . CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 2000; 68:821-61. DOI: 10.1146/annurev.biochem.68.1.821. View

12.

Nonaka M, Kim R, Fukushima H, Sasaki K, Suzuki K, Okamura M . Region-specific activation of CRTC1-CREB signaling mediates long-term fear memory. Neuron. 2014; 84(1):92-106. DOI: 10.1016/j.neuron.2014.08.049. View

13.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

14.

Tabusa H, Brooks T, Massey A . Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling. Mol Cancer Res. 2012; 11(2):109-21. DOI: 10.1158/1541-7786.MCR-12-0466. View

15.

Wells C, Abo A, Ridley A . PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J Cell Sci. 2002; 115(Pt 20):3947-56. DOI: 10.1242/jcs.00080. View

16.

Zhu G, Wang Y, Huang B, Liang J, Ding Y, Xu A . A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells. Oncogene. 2011; 31(8):1001-12. DOI: 10.1038/onc.2011.294. View

17.

Vershinin Z, Feldman M, Chen A, Levy D . PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway. J Biol Chem. 2016; 291(13):6786-95. PMC: 4807267. DOI: 10.1074/jbc.M115.697292. View

18.

Wong L, Chen N, Karantza V, Minden A . The Pak4 protein kinase is required for oncogenic transformation of MDA-MB-231 breast cancer cells. Oncogenesis. 2013; 2:e50. PMC: 3740299. DOI: 10.1038/oncsis.2013.13. View

19.

Ahn H, Jang J, Lee J, Se Hoon P, Park J, Park Y . P21-activated kinase 4 overexpression in metastatic gastric cancer patients. Transl Oncol. 2011; 4(6):345-9. PMC: 3243657. DOI: 10.1593/tlo.11145. View

20.

Park M, Lee H, Lee C, You S, Kim D, Park B . p21-Activated kinase 4 promotes prostate cancer progression through CREB. Oncogene. 2012; 32(19):2475-82. DOI: 10.1038/onc.2012.255. View